Table 5.
Absolute risk of subsequently developing any, palpable, or advanced prostate cancer by PSA level at age 44–50, and cumulative proportion of cancers above percentiles of PSA at age 44–50. The 95% confidence intervals are given in parentheses.
| Percentile | PSA (ng/ml)* | Any cancer | Palpable cancer | Advanced cancer | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Absolute risk, % | Cumulative proportion, % | Absolute risk, % | Cumulative proportion, % | Absolute risk, % | Cumulative proportion, % | ||
| 90 | 1.46 | 18 (17, 20) | 32 (29, 35) | 12 (11, 12) | 34 (30, 38) | 6.1 (5.5, 6.8) | 39 (33, 44) |
| 80 | 1.07 | 14 (13, 14) | 49 (45, 52) | 8.2 (7.7, 8.7) | 50 (45, 54) | 4.2 (3.8, 4.5) | 55 (48, 61) |
| 75 | 0.95 | 12 (12, 13) | 56 (53, 60) | 7.2 (6.7, 7.7) | 57 (53, 62) | 3.6 (3.3, 3.9) | 63 (58, 69) |
| 67 | 0.83 | 11 (10, 11) | 65 (61, 68) | 6.1 (5.7, 6.6) | 66 (62, 69) | 3.0 (2.7, 3.3) | 69 (63, 74) |
| 50 | 0.63 | 7.7 (6.9, 8.4) | 79 (76, 82) | 4.3 (3.8, 4.9) | 80 (76, 83) | 2.1 (1.8, 2.4) | 81 (77, 86) |
| 25 | 0.42 | 4.7 (3.7, 5.5) | 92 (90, 94) | 2.5 (1.8, 3.2) | 92 (89, 94) | 1.2 (0.8, 1.6) | 93 (90, 96) |
| 10 | 0.28 | 2.5 (1.2, 3.7) | 99 (98, 99) | 1.3 (0.5, 2.1) | 99 (97, 100) | 0.6 (0.2, 1.1) | 99 (97, 100) |
*
Imputed to the whole population from case-control data